Evidence map›Paper›PMID 31581603›Full record

ArticleMetabolites2019

Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD.

Shama Naz, Maria Bhat, Sara Ståhl, Helena Forsslund, C Magnus Sköld, Åsa M Wheelock, Craig E Wheelock

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02627872 (Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02627872 active not recruitingnot on this map

Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease

TypeobservationalSponsorKarolinska InstitutetRan2007 to 2030Enrolled120ConditionsChronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Chronic Airways Obstruction
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Respiratory diseases and the gut microbiota: an updated review.Frontiers in cellular and infection microbiology · 2025
    Review
  8. Article
  9. Kynurenine Pathway in Respiratory Diseases.International journal of tryptophan research : IJTR · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shama NazDivision of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE 171 77 Stockholm, Sweden. shamanishu@yahoo.com.
Maria BhatResearch and Development, Innovative Medicines, Personalised Healthcare and Biomarkers, Translational Science Centre, Science for Life Laboratory, AstraZeneca, SE 171 65 Solna, Sweden. Maria.Bhat@astrazeneca.com.
Sara StåhlResearch and Development, Innovative Medicines, Personalised Healthcare and Biomarkers, Translational Science Centre, Science for Life Laboratory, AstraZeneca, SE 171 65 Solna, Sweden.
Helena ForsslundRespiratory Medicine Unit, Department of Medicine Solna & Center for Molecular Medicine, Karolinska Institutet, SE 171 77 Stockholm, Sweden.
C Magnus SköldRespiratory Medicine Unit, Department of Medicine Solna & Center for Molecular Medicine, Karolinska Institutet, SE 171 77 Stockholm, Sweden. Magnus.Skold@ki.se.
Åsa M WheelockRespiratory Medicine Unit, Department of Medicine Solna & Center for Molecular Medicine, Karolinska Institutet, SE 171 77 Stockholm, Sweden. asa.wheelock@ki.se.
Craig E WheelockDivision of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE 171 77 Stockholm, Sweden. craig.wheelock@ki.se.
Karolinska Institutet · SEScience for Life Laboratory · SE

Funding

AFA Försäkring AFAChAMP (Centre for Allergy Research Highlights Asthma Markers of Phenotype) consortium which is funded by the Swedish Foundation for Strategic Research, the Karolinska Institutet, AstraZeneca & Science for Life Laboratory Joint Research Collaboration, and ChAMPFinnish Anti-Tuberculosis Association Foundation COSMICHjärt-Lungfonden 20170734Hjärt-Lungfonden 20180290Karolinska Institutet and AstraZeneca Joint Research Program in Translational Science ChAMPKing Gustaf V and Queen Victoria's Freemasons Foundation COSMICKing Oscar II Jubilee Foundation COSMICRegional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet ALFSixth Framework Programme Marie CurieStiftelsen för Strategisk Forskning SSFVetenskapsrådet 2016-02798VINNOVA VINN-MER
6 · The paper itself

Abstract

Increased activity of indoleamine 2,3-dioxygenase (IDO) and tryptophan hydroxylase (TPH) have been reported in individuals with chronic obstructive pulmonary disease (COPD). We therefore investigated the effect of gender stratification upon the observed levels of tryptophan metabolites in COPD. Tryptophan, serotonin, kynurenine, and kynurenic acid were quantified in serum of never-smokers (

Indexed as

COPDgenderIDOkynurenineserotoninsmokingtryptophan

Identifiers

PMID31581603
PMCPMC6835831
OpenAlexW2978418056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.